Eleven integrated health systems, with more than 16 million members, have combined de-identified data from their electronic health records to form the largest, most comprehensive private-sector diabetes registry in the nation. According to a new study published in the Centers for Disease Control...
R-Tech Ueno (JASDAQ:4573) is pleased to announce protocol amendment of a Phase I Clinical Study of RK-023, a new compound being developed for the treatment of hypotrichosis of the eyelashes (Note). The details are given below. R-Tech Ueno has been developing this new compound (development code...